SEED Therapeutics Inc. has announced that its molecular glue therapy, ST-01156, has been granted Rare Pediatric Disease and ...

The field of cancer treatment is witnessing rapid advancements due to progress in proteomics, genomics, and drug discovery. These technologies have ...

In a report released yesterday, Matthew Biegler from Oppenheimer reiterated a Buy rating on Nurix Therapeutics (NRIX – Research Report), with a ...

The human genome encodes potentially thousands of tiny proteins that were previously overlooked. The search is on to find out ...

Reported a robust objective response rate of 75.5% from the Phase 1 study of NX-5948 in patients with relapsed/refractory CLL/SLL at the 66th American Society of Hematology Annual Meeting Received ...

Oral Macromolecular Formulation Market To Expand At A 5.2% CAGR To Reach A Valuation Of US$ 31.7 Million By 2034 Explore the Pharmaceutical market's evolution in oral macromolecular drug formulations, ...